EMERYVILLE, Calif., March 6, 2012 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide® compounds for the local non-systemic treatment and prevention of infections, today announced that Ron Najafi, Chief Executive Officer, will present at the 24th Annual ROTH Conference, held March 11-14, 2012, in Dana Point, California. Later that month, Tom Paulson, Chief Financial Officer, will present at the 5th Annual Maxim Group Growth Conference, held on March 26, 2012, in New York, New York.
